The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fulvestrant versus everolimus plus exemestane for patients with metastatic breast cancer resistant to aromatase inhibitors: Clinical experience from real world.
 
Yi Li
No Relationships to Disclose
 
Yizhao Xie
No Relationships to Disclose
 
Yannan Zhao
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Shen Chen
No Relationships to Disclose
 
Chengcheng Gong
No Relationships to Disclose
 
Sheng Zhang
No Relationships to Disclose
 
Leiping Wang
No Relationships to Disclose
 
Biyun Wang
No Relationships to Disclose